EUVIMEDEUVIMED entdecken
Crossref

The Frequency of Differentiated Thyroid Cancer Recurrence in 2302 Patients With Excellent Response to Primary Therapy

Iwona Pałyga iD, Maciej Rumian, Alicja Kosel, Maciej Albrzykowski, Paulina Krawczyk, Agata Kalwat, Danuta Gąsior-Perczak, Agnieszka Walczyk, Artur Kuchareczko, Janusz Kopczyński, Magdalena Chrapek, Stanisław Góźdź und 1 weitere

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgad571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Iwona Pałyga und 12 weiteren Autor:innen. Beteiligte Einrichtung: Collegium Medicum, Jan Kochanowski University, Kielce 25-317, Poland. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Thyroid Neoplasms, Thiocarbamates, Adenocarcinoma, Follicular. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Minister of Education and Science, Regional Initiative of Excellence.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Discrepant data on the recurrence rate of differentiated thyroid cancer (DTC) are reported.

Objective

To evaluate the frequency and risk factors of true recurrence in DTC patients with excellent responses (ExR) to initial therapy.

Methods

A retrospective analysis of the 2302 consecutive DTC patients with ExR to primary therapy, treated during 24 years at single center. The percentage of recurrence and cumulative recurrence rate (CRR) were analyzed. Risk factors for recurrence for patients with papillary thyroid cancer (PTC) were investigated and methods for establishing a diagnosis of recurrence were evaluated.

Results

Of DTC patients, 32 (1.4%) experienced recurrence. PTC patients with recurrence were more likely to have younger age (P = .0182), larger tumor size (P = .0013), lymph node metastases (P = .0013), incomplete resection (P = .0446), higher ATA risk (P = .0002), and had more frequently been treated with 131I (P = .0203). CRRs at 5, 10, 15, 20, and 24 years after surgery were 1.2%, 1.9%, 2.5%, 2.9%, and 2.9%, respectively. The CRRs according to histological type were highest for poorly differentiated thyroid cancer (PDTC), lower for oncocytic (OTC) and follicular thyroid cancer (FTC), and lowest for PTC. Most recurrences occurred within the first 5 years of observation. The most effective method for detecting local recurrence was ultrasonography with fine needle aspiration cytology, and for distant metastases, 18F-FDG PET.

Conclusion

True recurrence is rare in DTC patients. PTC patients with ExR to primary therapy and N0/Nx can be dismissed from oncological follow-up. Despite ExR to primary therapy, DTC patients with N1, and PDTC, OTC, FTC should remain under oncological follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesThyroid NeoplasmsThiocarbamatesAdenocarcinoma, FollicularHumansRetrospective StudiesThyroid Cancer, PapillaryNeoplasm Recurrence, LocalThyroidectomyProline

Stichwörter der Autor:innen

DTCrecurrencethyroid carcinoma

Substanzen

Iodine-131Iodine RadioisotopesprolinedithiocarbamateProlineThiocarbamates

Autor:innen und Institutionen

  • Collegium Medicum, Jan Kochanowski University, Kielce 25-317, Poland.
  • Endocrinology Clinic, Holycross Cancer Centre, Kielce 25-734, Poland.
  • Department of Pathology, Holycross Cancer Centre, Kielce 25-734, Poland.
  • Department of Mathematics, Faculty of Natural Sciences, Jan Kochanowski University, Kielce 25-406, Poland.
  • Department of Clinical Oncology, Holycross Cancer Centre, Kielce 25-734, Poland.

ORCID-Profile: Iwona Pałyga

Förderung

  • Minister of Education and Science
  • Regional Initiative of Excellence

Zitieren

APA

Pałyga, I., Rumian, M., Kosel, A., Albrzykowski, M., Krawczyk, P., Kalwat, A., Gąsior-Perczak, D., Walczyk, A., Kuchareczko, A., Kopczyński, J., Chrapek, M., Góźdź, S., & Kowalska, A. (2024). The Frequency of Differentiated Thyroid Cancer Recurrence in 2302 Patients With Excellent Response to Primary Therapy. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad571

Vancouver

Pałyga I, Rumian M, Kosel A, Albrzykowski M, Krawczyk P, Kalwat A, et al. The Frequency of Differentiated Thyroid Cancer Recurrence in 2302 Patients With Excellent Response to Primary Therapy. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad571

BibTeX
@article{Payga2024,
  author = {Pałyga, Iwona and Rumian, Maciej and Kosel, Alicja and Albrzykowski, Maciej and Krawczyk, Paulina and Kalwat, Agata and Gąsior-Perczak, Danuta and Walczyk, Agnieszka and Kuchareczko, Artur and Kopczyński, Janusz and Chrapek, Magdalena and Góźdź, Stanisław and Kowalska, Aldona},
  title = {The Frequency of Differentiated Thyroid Cancer Recurrence in 2302 Patients With Excellent Response to Primary Therapy},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgad571}
}
Kostenlos starten →